Malignant brain tumor cells often migrate into surrounding healthy brain tissue, making these tumors extremely difficult or impossible to cure even after surgery, radiation and chemotherapy. These highly migratory cells follow fibrous tracks that are part of the brain’s neural topography. Migratory cells resist clinical treatments and often produce a fatal tumor recurrence.
Mariano Viapiano, a researcher at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) is collaborating with John Lannutti, professor of materials science and engineering in Ohio State’s College of Engineering, and others, to develop biologically compatible nanofibers that mimic the neural topography used by migratory tumor cells.
“We were trying to improve our understanding of how cancer invades in the brain and other organs,” says Viapiano, a member of the Center for Molecular Neurobiology and the Molecular Biology and Cancer Genetics Research Program at OSUCCC-James. “We have found the behavior of tumor cells is much more similar to the behavior in the real tumor when we grow them on these nanofibers instead of conventional, rigid plastic petri dishes.”
The nanofibers are so small that their general structure can only be observed in a scanning electron microscope. For perspective, it would take nearly 100 nanofibers side-by-side to equal the width of one human hair.
For generations, scientists have used petri dishes to grow living cells in the laboratory. But the cancer cells they observed and treated in this two-dimensional environment behaved much differently than they did in three-dimensional human tissue.
In contrast, nanofibers form spider web-like three-dimensional cell cultures in which cancer cells move and climb much as they do in human tissue.
“We want to analyze cells behaving in a manner more representative to how they behave in patients,” said Viapiano, who is an assistant professor of neurological surgery in the College of Medicine. “This is a significant improvement because it is giving us a new environment to culture the cells.”
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (cancer.osu.edu) is one of only 40 Comprehensive Cancer Centers in the United States designated by the National Cancer Institute. Ranked by U.S. News & World Report among the top cancer hospitals in the nation, The James is the 180-bed adult patient-care component of the cancer program at The Ohio State University. The OSUCCC-James is one of only seven funded programs in the country approved by the NCI to conduct both Phase I and Phase II clinical trials.
Medical Center Public Affairs and Media Relations